Hytrin BPH 1 mg und 2 mg
Hytrin BPH 1 mg und 2 mg is a medicine authorised by Swissmedic under authorisation number 52342. The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 October 1994 and the authorisation is valid without a time limit. ATC code G04CA03 places the medicine in the group Urologicals.
| Authorisation number | 52342 |
|---|---|
| Name | Hytrin BPH 1 mg und 2 mg |
| Full name | Hytrin BPH 1 mg und 2 mg, Tabletten |
| Authorisation holder | Advanz Pharma Specialty Medicine Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G04CA03 |
| First authorisation | 21 October 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Hytrin BPH 1 mg und 2 mg, Tabletten | B | 21 October 1994 |
| 3 | Hytrin BPH 5 mg, Tabletten | B | 21 October 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 1 | Set | G04CA03 | 05.99.0. | B |
| 23 | 20 | Tablette(n) | G04CA03 | 05.99.0. | B |
| 31 | 60 | Tablette(n) | G04CA03 | 05.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Hytrin BPH 1 mg und 2 mg authorised in Switzerland?
Yes. Hytrin BPH 1 mg und 2 mg is authorised by Swissmedic under authorisation number 52342, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Hytrin BPH 1 mg und 2 mg have?
Hytrin BPH 1 mg und 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Hytrin BPH 1 mg und 2 mg?
The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.